Radiotherapeutic management of liver metastases in colorectal cancer

David Hauerstock, Walter Choi

Research output: Contribution to journalArticlepeer-review


The liver is the most common site of distant metastases in patients with colorectal cancer, and liver metastases are a frequent cause of death in this patient population. Chemotherapy is the standard treatment, with an expected median survival reaching approximately 2 years. Resection of metastases can achieve long-term cure in a small proportion of these patients. For unresectable or inoperable patients, several options for local ablative therapy exist, including radiofrequency ablation, chemoembolization, and cryotherapy. This review will discuss 2 radiotherapeutic approaches that are of growing interest due to the prospect of reducing treatment-related morbidity: external beam/stereotactic body radiation therapy, and yttrium-90 radio embolization.

Original languageEnglish
Pages (from-to)126-130
Number of pages5
JournalSeminars in Colon and Rectal Surgery
Issue number2
StatePublished - Jun 2010
Externally publishedYes


Dive into the research topics of 'Radiotherapeutic management of liver metastases in colorectal cancer'. Together they form a unique fingerprint.

Cite this